ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Overview Fund Activity
Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

61 hedge funds and large institutions have $33.5M invested in Adamas Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
11
Increased
14
Reduced
25
Closed
22
Calls
$66K
Puts
$29K
Net Calls
+$37K
Net Calls Change
-$496K

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$2.46M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$1.92M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.21M
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$1.08M
5
Jane Street
5
Jane Street
New York
$351K

Top Sellers

1
Macquarie Group
1
Macquarie Group
Australia
$0
2
BlackRock
2
BlackRock
New York
$1.53M
3
SCM
3
Stonepine Capital Management
Oregon
$1.94M
4
State Street
4
State Street
Massachusetts
$128K
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
1
Armistice Capital
New York
$7.02M – – –
OM
2
Opaleye Management
Massachusetts
$2.46M +$2.46M +960,000 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.38M -$124K -48,286 -5%
Renaissance Technologies
4
Renaissance Technologies
New York
$2.21M +$1.19M +463,874 +116%
SCM
5
Stonepine Capital Management
Oregon
$1.94M -$1.04M -405,172 -35%
Assenagon Asset Management
6
Assenagon Asset Management
Luxembourg
$1.92M +$1.92M +750,948 New
EA
7
Emerald Advisers
Pennsylvania
$1.71M +$96.3K +37,595 +6%
EMFAT
8
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.59M +$64K +25,000 +4%
BlackRock
9
BlackRock
New York
$1.53M -$3.03M -1,182,408 -66%
AQR Capital Management
10
AQR Capital Management
Connecticut
$1.08M +$521K +203,582 +94%
Nuveen Asset Management
11
Nuveen Asset Management
Illinois
$945K -$285K -111,112 -23%
DAM
12
Deltec Asset Management
New York
$911K -$118K -46,000 -11%
Morgan Stanley
13
Morgan Stanley
New York
$892K -$428K -166,947 -32%
WVP
14
Worth Venture Partners
New Jersey
$624K +$222K +86,564 +55%
BCM
15
Bridgeway Capital Management
Texas
$474K +$231K +90,000 +95%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$471K +$273K +106,517 +137%
BBA
17
Baker Bros. Advisors
New York
$442K – – –
BOS
18
Bingham Osborn & Scarborough
California
$441K – – –
Geode Capital Management
19
Geode Capital Management
Massachusetts
$403K -$354K -138,287 -47%
Jane Street
20
Jane Street
New York
$351K +$351K +137,292 New
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$324K -$96.3K -37,653 -23%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$313K +$266K +104,076 +572%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$302K -$90.2K -35,234 -23%
Goldman Sachs
24
Goldman Sachs
New York
$265K +$41.3K +16,090 +18%
BBVA
25
Banco Bilbao Vizcaya Argentaria
Spain
$256K +$256K +100,000 New
1
2 3 4